NASDAQ: XGNExagen Inc Stock Ownership - Who owns Exagen?
Insider buying vs selling
Have Exagen Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| John Aballi | President and CEO | 2025-10-16 | 31,787 | $11.82 | $375.60kSell |
| Jeffrey G. Black | Chief Financial Officer | 2025-09-02 | 20,466 | $9.79 | $200.36kSell |
| Nmsic Coinvestment Fund LP | 10% Owner | 2025-03-25 | 350,000 | $3.30 | $1.16MSell |
| John Aballi | President and CEO | 2025-02-28 | 8,621 | $2.47 | $21.25kBuy |
XGN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when XGN insiders and whales buy or sell their stock.
XGN Shareholders
What type of owners hold Exagen Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| James L. L. Tullis | 13.67% | 3,098,926 | $20.92M | Insider |
| Nmsic Coinvestment Fund LP | 7.81% | 1,771,032 | $11.95M | Insider |
| Rtw Investments LP | 7.49% | 1,696,866 | $11.45M | Institution |
| Hig Bioexagen LP | 7.48% | 1,696,252 | $11.45M | Insider |
| Tullis Dickerson Capital Focus III LP | 7.17% | 1,625,264 | $10.97M | Insider |
| Hunt Holdings Limited Partnership | 5.57% | 1,261,324 | $8.51M | Insider |
| John Aballi | 3.33% | 754,828 | $5.10M | Insider |
| Vanguard Group Inc | 3.24% | 733,824 | $4.95M | Institution |
| Balyasny Asset Management LP | 3.19% | 723,428 | $4.88M | Institution |
| Invesco Ltd | 2.98% | 675,192 | $4.56M | Institution |
XGN vs Diagnostic & Research Stocks
Exagen Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.